Pediatric Diabetes Therapeutic Market Analysis by Drug Therapy and Insulin Therapy through 2034

<p>The global <strong>pediatric diabetes therapeutic market</strong> is set to reach USD 1,633.8 million in 2024. Projections indicate that the sector is anticipated to elevate to USD 2,612.4 million by 2034. The industry stood at USD 1,540.2 million in 2023 and is anticipated to exhibit a Y-o-Y growth of 6.1% in 2024. Demand for pediatric diabetes therapeutics is slated to surge at a 4.8% CAGR.</p><table> <tbody> <tr> <th scope='row'>Attributes</th> <td>Description</td> </tr> <tr> <th scope='row'>Estimated Global Pediatric Diabetes Therapeutic Market Size (2024E)</th> <td>USD 1,633.8 million</td> </tr> <tr> <th scope='row'>Projected Global Pediatric Diabetes Therapeutic Market Value (2034F)</th> <td>USD 2,612.4 million</td> </tr> <tr> <th scope='row'>Value-based CAGR (2024 to 2034)</th> <td>4.8%</td> </tr> </tbody></table><p>Country-wise Insights</p><table> <tbody> <tr> <th scope='row'>Countries</th> <td>CAGR 2024 to 2034</td> </tr> <tr> <th scope='row'>United States</th> <td>5.4%</td> </tr> <tr> <th scope='row'>China</th> <td>5.3%</td> </tr> <tr> <th scope='row'>Germany</th> <td>4.8%</td> </tr> <tr> <th scope='row'>United Kingdom</th> <td>4.4%</td> </tr> <tr> <th scope='row'>India</th> <td>4.5%</td> </tr> </tbody></table><p>Category-wise Insights</p><table> <tbody> <tr> <th scope='row'>Segment</th> <td>Type 1 (Diabetes)</td> </tr> <tr> <th scope='row'>Value Share (2024)</th> <td>56.2%</td> </tr> </tbody></table><table> <tbody> <tr> <th scope='row'>Segment</th> <td>Insulin Therapy (Therapy)</td> </tr> <tr> <th scope='row'>Value Share (2024)</th> <td>57.2%</td> </tr> </tbody></table>

<p>全球儿童糖尿病治疗市场预计将于2024年达到16.338亿美元。据预测，该领域预计将在2034年攀升至26.124亿美元。2023年，该行业价值为15.402亿美元，预计2024年将呈现6.1%的年度同比增长。儿童糖尿病治疗药物的需求预计将以4.8%的复合年增长率激增。</p><table> <tbody> <tr> <th scope='row'>属性</th> <td>描述</td> </tr> <tr> <th scope='row'>预计全球儿童糖尿病治疗市场规模（2024年估计值）</th> <td>16.338亿美元</td> </tr> <tr> <th scope='row'>预计全球儿童糖尿病治疗市场价值（2034年预测值）</th> <td>26.124亿美元</td> </tr> <tr> <th scope='row'>基于价值的复合年增长率（2024年至2034年）</th> <td>4.8%</td> </tr> </tbody></table><p>按国家洞察</p><table> <tbody> <tr> <th scope='row'>国家</th> <td>2024年至2034年复合年增长率</td> </tr> <tr> <th scope='row'>美国</th> <td>5.4%</td> </tr> <tr> <th scope='row'>中国</th> <td>5.3%</td> </tr> <tr> <th scope='row'>德国</th> <td>4.8%</td> </tr> <tr> <th scope='row'>英国</th> <td>4.4%</td> </tr> <tr> <th scope='row'>印度</th> <td>4.5%</td> </tr> </tbody></table><p>按类别洞察</p><table> <tbody> <tr> <th scope='row'>细分市场</th> <td>1型糖尿病</td> </tr> <tr> <th scope='row'>价值份额（2024年）</th> <td>56.2%</td> </tr> </tbody></table><table> <tbody> <tr> <th scope='row'>细分市场</th> <td>胰岛素疗法（治疗）</td> </tr> <tr> <th scope='row'>价值份额（2024年）</th> <td>57.2%</td> </tr> </tbody></table></p>